ArticleFrontiers in endocrinology2025
A cross-sectional study of testosterone deficiency and inflammatory markers in older men.
Article in Frontiers in endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- System-level clustering of testosterone-related biomarkers identifies high-risk aging profiles linked to inflammation and renal function.Communications medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: This cross-sectional study aimed to examine the relationship between total testosterone (TT) levels, the diagnosis of testosterone deficiency syndrome (TDS), and high-sensitivity C-reactive protein (hsCRP) concentrations in aging men. The analysis also included selected hormonal and anthropometric parameters. Methods: Serum hsCRP levels were measured. Additionally, serum levels of TT, estradiol (E2), dehydroepiandrosterone sulfate (DHEA-S), insulin (I), and sex hormone-binding protein (SHBG) were assessed using ELISA. Patients were divided based on the presence or absence of a TDS diagnosis. Results: In patients without TDS, no significant correlation was observed between hsCRP levels and other measured variables. However, higher hsCRP levels were associated with an increased BMI, larger waist and hip circumferences, and elevated triglyceride (TAG) levels compared to patients with lower hsCRP concentrations. Conclusions: The co-occurrence of testosterone deficiency and elevated inflammatory markers such as hsCRP was associated with less favorable metabolic and anthropometric profiles. While causality cannot be inferred from this observational study, the findings suggest a possible link between systemic inflammation and testosterone deficiency in aging men. These associations merit further investigation in longitudinal and mechanistic studies to clarify directionality and underlying biological pathways.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.